April 27, 2017
BASF profit €322M up in Q1 2017
BASF, a Germany based chemical company has reported results for Q1 2017.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
April 26, 2017
FDA warns 14 USA companies selling fake treatments for cancer
The U.S. Food and Drug Administration today posted warning letters addressed to 14 U.S.-based companies illegally selling more than 65 products that fraudulently claim to prevent, diagnose, treat or cure cancer.
April 26, 2017
J&J, Takeda among interested in Brazil’s Hypermarcas, sources say
Johnson & Johnson <JNJ.N>, Novartis AG <NOVN.S> and Takeda Pharmaceutical Co Ltd <4502.T> have expressed interest in a buyout of the controlling stake that two families have in Brazilian drugmaker Hypermarcas SA <HYPE3.SA>, two people with knowledge of the matter said on Monday
April 25, 2017
Orexigen closer to weight loss product deal in canada
Orexigen Therapeutics said that Health Canada has accepted to review a New Drug Submission for marketing approval of its products Contrave (naltrexone HCl and bupropion HCl).
April 25, 2017
Bristol-Myers and Transgene testing combination of their cancer drugs
Bristol-Myers Squibb and Transgene have entered a new clinical research collaboration to evaluate the safety, tolerability and efficacy of Transgene’s investigational therapeutic vaccine TG4010 in combination with Bristol-Myers Squibb’s Opdivo (nivolumab) + standard chemotherapy (CT) as a first-line treatment for advanced non-squamous non-small cell lung cancer (NSCLC) in patients whose tumors have low or undetectable levels of PD-L1.
April 24, 2017
Bayer parners up with Goodbye Malaria to end malaria
Bayer has partnered up with Goodbye Malaria to support the objectives of Ending Malaria for Good in Southern Africa.
April 24, 2017
Lilly’s breast cancer drug study meets primary goal
Eli Lilly’s MONARCH 3 trial has met its primary endpoint of demonstrating statistically significant improvement in progression-free survival (PFS).
April 24, 2017
Stada welcomes new managing director
STADA Arzneimittel AG has appointed Dr. Ralph Grobecker as Managing Director at STADA GmbH.
April 24, 2017
Tiziana testing drug for fifth most common cancer
Tiziana Life Sciences a cancer drugs making focused clinical stage biotechnology company got approval in Israel to start testing inhibitor of cell cycle dependent kinases (CDKs), milciclib in a phase II clinical trial.
April 24, 2017
Amryt starts patient testing for rare skin disease
Amryt, the pharmaceutical company focused on treatments for rare and orphan diseases, has enroled first patient into “EASE”, the company’s pivotal Phase 3 clinical trial, which is evaluating AP101 as a potential treatment for the rare, genetic skin disorder, Epidermolysis Bullosa (“EB”).